Clinical Trial Update: Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients [NA]

View source ↗

Summary

Clinical trial update on the combination of nimotuzumab with paclitaxel liposome and carboplatin (the TP regimen) for advanced non-small cell lung cancer, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nimotuzumab (nimotuzumab)
• Paclitaxel liposome (liposomal paclitaxel)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non-small Cell Lung Cancer | NA | Status: UNKNOWN